Recursion Pharmaceuticals (RXRX)
Nasdaq • RXRX • US75629V1044
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 26.4% of free float sold short, 5.2 days to cover, cost to borrow 0.84%. Sign up for live short interest data.
Market Cap
2.24b USD | # 3750 in US
Volume
22.73m shares | 83.71m USD
Shares Outstanding
622.76m
Free Float Shares
98.26% | 611.95m
